Skip to content
Search

Latest Stories

Top Stories

Bill of the month: Limiting Chinese influence in the biotech sector

WuXi AppTec building

The BIOSECURE Act takes direct aim at five Chinese companies, including WuXi AppTec.

CFOTO/Future Publishing via Getty Images

Rogers is the “data wrangler” at BillTrack50. He previously worked on policy in several government departments.

This month IssueVoter and BillTrack50 take a look at the BIOSECURE Act, a significant escalation in efforts to restrict Chinese influence in America's biotechnology sector.

The bipartisan legislation, passed by the House of Representatives in September and spearheaded by Reps. Brad Wenstrup (R-Ohio) and Raja Krishnamoorthi (D-Ill.), aims to protect American patient data and prevent federal funds from flowing to biotechnology companies deemed to pose national security risks.


Key Provisions

At its core, the BIOSECURE Act seeks to create a firewall between federal agencies and certain biotechnology companies. Under the legislation, federal agencies would be barred from contracting with designated "biotechnology companies of concern" or providing grants and loans to entities that use their services.

This prohibition extends to organizations that maintain contracts with these companies, creating a ripple effect throughout the biotechnology supply chain.

The bill takes direct aim at five Chinese companies: BGI, MGI, Complete Genomics, WuXi AppTec,and WuXi Biologics. Beyond these specific designations, it establishes a framework for identifying additional companies as security risks, particularly those controlled by "foreign adversaries" including China, Russia, North Korea, Iran and Cuba.

Weaponizing Our Genome

Supporters of the BIOSECURE Act, with Wenstrup at the forefront, paint a concerning picture of vulnerable national security and compromised patient privacy.

As Krishnamoorthi dramatically frames the issue: "As Americans have their blood drawn or take other medical tests each day, few have any idea that their personal genetic information could be going to biotech companies controlled by the Chinese Communist Party and other adversaries that would weaponize our own genomes against us."

The military connections between Chinese biotech firms and the People's Liberation Army have raised additional red flags. These relationships reportedly extend beyond mere collaboration to include joint research projects and shared genetic collection sites. The fact that WuXi AppTec derives over 60 percent of its revenue from the U.S. market has intensified concerns about American dependency on potentially compromised supply chains.

Perhaps most alarming to supporters is China's legal framework requiring companies to share data with the government upon request. This mandate creates a direct pipeline for sensitive genetic information about American citizens to flow into the hands of Chinese authorities.

Opposition and Concerns

Yet the legislation has drawn significant criticism, even from unexpected quarters. Rep. Jim McGovern (D-Mass.), known for his tough stance on China, has emerged as a prominent critic. In his forceful opposition to the bill, McGovern argues: "Naming specific companies will create a 'whack-a-mole' situation where entities can change their name and reincorporate to evade sanctions. ... [I]t's totally wrong to call out specific companies without any formal investigation or interagency process —that might be how they do things in the PRC, but this is the United States of America where we ought to have a thorough, independent investigation."

Company Responses

Health care technology executives have added their voices to the chorus of concern. At the Clinical Trial Supply West Coast 2024 conference, Umar Hayat of Gladius Therapeutics offered a stark warning:"This seems more like politics rather than about a security threat. ... [I]f you want to play politics, play politics in other industries like automotive, electronics or telecommunications. Don't play politics in health care where so many people are in dire need. Let science evolve and advance — wherever it comes from."

BGI has mounted a vigorous defense against the allegations, emphasizing that it maintains no direct patient services in the United States and therefore has no access to Americans' personal data. The company has clarified that its Covid-19 PCR testing analyzes only viral RNA, not patient DNA, and stressed its status as a privately owned entity independent from Chinese government control. BGI likens its gene bank operations to those of U.S. national laboratories, suggesting that fears about its activities may be overblown.

Broader Implications

The BIOSECURE Act represents more than a simple regulatory change; it signals a fundamental shift in how the United States approaches biotechnology in the context of national security. This transformation raises complex questions about the future of international scientific collaboration at a time when global cooperation has proven crucial for addressing health challenges.

The legislation could trigger a significant reorganization of pharmaceutical supply chains, with countries like Ireland and India potentially emerging as alternative manufacturing locations. However, this restructuring comes with its own set of challenges and uncertainties.

Innovation in the biotechnology sector could face headwinds as restrictions on collaboration with Chinese firms affect the development pipeline for new treatments. The legislation also adds another layer of complexity to U.S.-China relations, potentially complicating ongoing dialogue in other areas.

Looking Ahead

As the BIOSECURE Act moves to the Senate with strong bipartisan support, its passage could mark a watershed moment in U.S. biotechnology policy. Policymakers face the delicate task of balancing legitimate national security concerns with the benefits of international scientific collaboration and market competition.

The debate over this legislation reflects deeper questions facing the biotechnology sector about the relationship between national security and scientific progress. How nations protect sensitive genetic data while maintaining scientific openness, and the role of national security considerations in health care innovation, will likely shape the future of global biotechnology development for years to come.

The answers to these questions will determine not just the future of U.S.-China relations in biotechnology, but the pace and direction of medical innovation in an increasingly interconnected world.

Read More

A child looks into an empty fridge-freezer in a domestic kitchen.

The Trump administration’s suspension of the USDA’s Household Food Security Report halts decades of hunger data tracking.

Getty Images, Catherine Falls Commercial

Trump Gives Up the Fight Against Hunger

A Vanishing Measure of Hunger

Consider a hunger policy director at a state Department of Social Services studying food insecurity data across the state. For years, she has relied on the USDA’s annual Household Food Security Report to identify where hunger is rising, how many families are skipping meals, and how many children go to bed hungry. Those numbers help her target resources and advocate for stronger programs.

Now there is no new data. The survey has been “suspended for review,” officially to allow for a “methodological reassessment” and cost analysis. Critics say the timing and language suggest political motives. It is one of many federal data programs quietly dropped under a Trump executive order on so-called “nonessential statistics,” a phrase that almost parodies itself. Labeling hunger data “nonessential” is like turning off a fire alarm because it makes too much noise; it implies that acknowledging food insecurity is optional and reveals more about the administration’s priorities than reality.

Keep ReadingShow less
Standing Up for Democracy Requires Giving the Other Side Credit When It Is Deserved

U.S. President Donald Trump poses with the signed agreement at a world leaders' summit on ending the Gaza war on October 13, 2025 in Sharm El-Sheikh, Egypt.

(Photo by Suzanne Plunkett - Pool / Getty Images)

Standing Up for Democracy Requires Giving the Other Side Credit When It Is Deserved

American political leaders have forgotten how to be gracious to their opponents when people on the other side do something for which they deserve credit. Our antagonisms have become so deep and bitter that we are reluctant to give an inch to our political adversaries.

This is not good for democracy.

Keep ReadingShow less
The Critical Value of Indigenous Climate Stewardship

As the COP 30 nears, Indigenous-led conservation offers the best hope to protect the Amazon rainforest and stabilize the global climate system.

Getty Images, photography by Ulrich Hollmann

The Critical Value of Indigenous Climate Stewardship

In August, I traveled by bus, small plane, and canoe to the sacred headwaters of the Amazon, in Ecuador. It’s a place with very few roads, yet like many areas in the rainforest, foreign business interests have made contact with its peoples and in just the last decade have rapidly changed the landscape, scarring it with mines or clearcutting for cattle ranching.

The Amazon Rainforest is rightly called the “lungs of the planet.” It stores approximately 56.8 billion metric tons of carbon, equivalent to nearly twice the world’s yearly carbon emissions. With more than 2,500 tree species that account for roughly one-third of all tropical trees on earth, the Amazon stores the equivalent to 10–15 years of all global fossil fuel emissions. The "flying rivers" generated by the forest affect precipitation patterns in the United States, as well our food supply chains, and scientists are warning that in the face of accelerating climate change, deforestation, drought, and fire, the Amazon stands at a perilous tipping point.

Keep ReadingShow less
Indiana Republicans Could Lose at the Ballot over Redistricting Plan
Image generated by IVN staff

Indiana Republicans Could Lose at the Ballot over Redistricting Plan

INDIANAPOLIS, Ind. -- As Indiana Republicans weigh whether to call a special session to redraw the state’s congressional map, a new Unite America poll shows that voters overwhelmingly oppose the idea — including a majority of GOP primary voters.

The survey, conducted October 7–9 by 3D Strategic Research, found that 44% of Hoosiers oppose mid-decade redistricting while only 31% support it. After hearing balanced arguments from both sides, opposition jumped to 69%, with just 21% still in favor.

Keep ReadingShow less